These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 10556185

  • 1. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease.
    Ware RE, Zimmerman SA, Schultz WH.
    Blood; 1999 Nov 01; 94(9):3022-6. PubMed ID: 10556185
    [Abstract] [Full Text] [Related]

  • 2. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.
    Cochrane Database Syst Rev; 2017 Jan 17; 1(1):CD003146. PubMed ID: 28094851
    [Abstract] [Full Text] [Related]

  • 3. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ, Kohli R, Hopewell S, Trivella M, Wang WC.
    Cochrane Database Syst Rev; 2020 Jul 27; 7(7):CD003146. PubMed ID: 32716555
    [Abstract] [Full Text] [Related]

  • 4. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH.
    J Pediatr; 2004 Sep 27; 145(3):346-52. PubMed ID: 15343189
    [Abstract] [Full Text] [Related]

  • 5. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A, Ware RE, Thornburg CD.
    Am J Hematol; 2011 Apr 27; 86(4):357-61. PubMed ID: 21442640
    [Abstract] [Full Text] [Related]

  • 6. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).
    Ware RE, Helms RW, SWiTCH Investigators.
    Blood; 2012 Apr 26; 119(17):3925-32. PubMed ID: 22318199
    [Abstract] [Full Text] [Related]

  • 7. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC, Dwan K.
    Cochrane Database Syst Rev; 2013 Nov 14; (11):CD003146. PubMed ID: 24226646
    [Abstract] [Full Text] [Related]

  • 8. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE, Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH).
    Am J Hematol; 2013 Nov 14; 88(11):932-8. PubMed ID: 23861242
    [Abstract] [Full Text] [Related]

  • 9. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.
    Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE.
    Blood; 2004 Mar 15; 103(6):2039-45. PubMed ID: 14630791
    [Abstract] [Full Text] [Related]

  • 10. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A, de Bisotti R, Sumoza D, Fairbanks V.
    Am J Hematol; 2002 Nov 15; 71(3):161-5. PubMed ID: 12410569
    [Abstract] [Full Text] [Related]

  • 11. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW.
    Pediatr Blood Cancer; 2011 Dec 01; 57(6):1011-7. PubMed ID: 21826782
    [Abstract] [Full Text] [Related]

  • 12. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
    Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE.
    Blood; 1999 Sep 01; 94(5):1550-4. PubMed ID: 10477679
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience.
    Jain DL, Apte M, Colah R, Sarathi V, Desai S, Gokhale A, Bhandarwar A, Jain HL, Ghosh K.
    Indian Pediatr; 2013 Oct 01; 50(10):929-33. PubMed ID: 23798623
    [Abstract] [Full Text] [Related]

  • 14. Use of hydroxyurea in prevention of stroke in children with sickle cell disease.
    Lefèvre N, Dufour D, Gulbis B, Lê PQ, Heijmans C, Ferster A.
    Blood; 2008 Jan 15; 111(2):963-4; author reply 964. PubMed ID: 18182580
    [No Abstract] [Full Text] [Related]

  • 15. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R, Hsieh MM, Zhao X, Calvaruso G, Rigano P, Renda D, Tisdale JF, Maggio A.
    Int J Mol Sci; 2018 Feb 28; 19(3):. PubMed ID: 29495591
    [Abstract] [Full Text] [Related]

  • 16. Sickle cell disease and stroke.
    Verduzco LA, Nathan DG.
    Blood; 2009 Dec 10; 114(25):5117-25. PubMed ID: 19797523
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 10; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.
    Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE.
    Blood; 2007 Aug 01; 110(3):1043-7. PubMed ID: 17429008
    [Abstract] [Full Text] [Related]

  • 19. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.
    Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles LA, Helms RW, Kinney TR, Ohene-Frempong K.
    Blood; 2002 Jan 01; 99(1):10-4. PubMed ID: 11756146
    [Abstract] [Full Text] [Related]

  • 20. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
    Lagunju I, Brown BJ, Oyinlade AO, Asinobi A, Ibeh J, Esione A, Sodeinde OO.
    Pediatr Blood Cancer; 2019 Mar 01; 66(3):e27252. PubMed ID: 29797633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.